It’s election season and time to elect HOPA’s new leadership. The President-Elect, Secretary, and At-Large Member provide crucial guidance in reaching our association’s strategic goals, including Professional Development, Resources and Tools; Research; and Advocacy.
Make Your Vote Count
Take a look at the candidates below and imagine how each could contribute to our vision of ensuring all individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team.
We wish you could vote for them all, but on the next page, you’ll need to make one selection for each position.
Cast Your Ballot
Lifetime, Full, and Technician members are eligible to vote and the deadline is Tuesday, December 2, 2020 at 5 p.m. CST. If you are not a current HOPA member, please click here to join now.
Learn More About the Candidates
Heidi D. Finnes, PharmD, BCOP, FHOPA
Senior Manager of Pharmacy Cancer Research and Director of the Pharmacy Shared Resource | Mayo Clinic Cancer Center
Assistant Professor of Pharmacy | Mayo Clinic College of Medicine
My name is Heidi Finnes, PharmD, BCOP, FHOPA and I am proud to be a candidate for President-Elect. I am the Senior Manager of Pharmacy Cancer Research and Director of the Pharmacy Shared Resource at Mayo Clinic, Rochester, MN. I am an Assistant Professor of Pharmacy and have been a proud Mayo Clinic employee for 22 years. I have been a HOPA member since 2004 and was an At-Large Board member from 2015-2019. I have been a member of the Annual Conference, Tools and Resources and Quality Committees. I was chair of the Annual Conference Committee, Session Proposal Subcommittee, and Time to Talk Immuno-Oncology Task Force.
Recently, I helped facilitate the Investigational Drug Service (IDS) Special Interest Group to become active in establishing best practices post-COVID-19. As President-Elect, I will advocate for HOPA to see COVID-19 challenges as opportunities for pharmacists. The healthcare paradigm has shifted to bring cancer care to the patient. Pharmacist provider status and oral chemotherapy parity must be realized during our tenure to expand access to healthcare. I will work with you to create bold, innovative pharmacy services in hospital, clinic, specialty, IDS and community pharmacy settings.
I support research on telehealth and quality metrics that highlight the vital role pharmacists play in cancer care. We must promote “Pharmacist Phorward” practice ideas to facilitate mentorship opportunities and create collaborations with outside organizations. Together, we can shape the future of oncology pharmacy. I would be honored to pursue these goals with you as President-Elect. Thank you for your consideration.
Amy Hatfield Seung, PharmD, BCOP, FHOPA
Senior Medical Director | MJH Life Sciences – Pharmacy Times Continuing Education Division
I am honored to be considered as a candidate for the President-Elect position on the HOPA Board of Directors. During my more than 15 years as a member of HOPA, I have seen tremendous growth in our organization, the skills and strengths of our membership, and our organization’s visibility to external organizations. Although my primary roles have evolved, my focus remains on education of practitioners to better care for their patients. My passions include the use of technologies, analytics, and evidence-based data to support these initiatives. While I have been involved on multiple committees over a number of years, I have also served as a representative to ASCO’s CancerLinQ Oncology Leadership Council.
If elected, I would work with the Board of Directors and you as members to continue to develop resources to help you strengthen your roles, show your value, anticipate changes to our profession, and be an advocate for your patients as our cancer care landscape continues to rapidly evolve. I would work on collaborative opportunities with external stakeholders to highlight outcomes of our work. One strength of HOPA is the ability to use members’ talents and vigor to prioritize goals and execute priorities efficiently. The teamwork mentality within our oncology pharmacy networks are lifelong and critical for continued maturation of our profession. I appreciate the opportunity to work with you and support this enthusiastic strong organization. Thank you for your time and consideration of your vote.
Amber P. Lawson, PharmD, BCOP
Program Coordinator | University of Kentucky HealthCare
It is an honor to be nominated for the Secretary position of the HOPA Board of Directors. I have been a member of HOPA for nearly 15 years and have served in various roles including the Nominations Subcommittee (Vice Chair/Chair), Governance Committee, Research Council, and Quality Oversight Committee. Throughout my career, I have had the opportunity to lead and support clinical teams, precept pharmacy student and resident learners, oversee high-impact clinical and administrative initiatives, evaluate research protocols and data safety monitoring at the Cancer Center level, and coordinate hematology/oncology formulary management. These experiences have given me a broad exposure and appreciation for the many important roles the hematology/oncology pharmacy department serves within the healthcare system.
Over time, we have witnessed the ever-increasing complexity of cancer care require hematology/oncology pharmacists and technicians to evolve their practices in order to meet patient needs. Through the expertise of its membership, HOPA provides the infrastructure to elevate and adapt our professional contributions to the changing healthcare landscape through the goals and objectives outlined within the strategic plan. If elected, I will work with the Board of Directors and membership to anticipate and evaluate opportunities and challenges that face us as we seek to advance our profession. It is important to build on existing relationships with other stakeholders and clearly communicate what HOPA offers our patients and our profession. I humbly ask for your vote in order to have the opportunity to represent the membership and advance the organization’s vision as we look forward.
Rebecca J. Fahrenbruch, PharmD, BCOP, FHOPA
Medical Science Liaison Myeloid Hematology | Bristol Myers Squibb
I am honored to be nominated for Secretary and look forward to continuing my service to HOPA. HOPA is your organization and I am so proud of everything it has accomplished. I have been a member since 2004 and have had opportunities to be involved in projects such as the Dose Rounding Position Statement initiative/publication and development of the HOPA Pilot Mentoring Program. I really enjoyed working on the Needs Assessment and Standards Committees and serving as the Leadership Development Subcommittee Vice-Chair/Chair.
We should continue to focus on what the organization should be doing to help hematology/oncology pharmacists and staff. I will listen to your ideas and am excited to hear your needs to improve patient care. I represent more than 20 years of oncology pharmacy practice including inpatient, outpatient, oral oncology, management and now industry. Our membership and needs are very diverse with professionals in many aspects of oncology and hematology practice. With my vast experience, I will bring ideas forward to implement and develop tools and programs to help further your professional career for all of HOPA members. My passions include mentoring, education, training, research and resource development. One of my top priorities is to continue a mentorship program for all HOPA members. It is an exciting time for HOPA with a new strategic plan and I will work hard to achieve the goals and initiatives of the organization to improve the care of our cancer patients through professional development, professional tools and resources, research and advocacy.
Andrea Iannucci, PharmD, BCOP
Assistant Chief Pharmacist; Oncology, and Investigational Drugs Oncology Clinical Pharmacy Specialist, Residency Director, PGY2 Oncology Specialty Residency | UC Davis Medical Center
Health Science Clinical Professor (WOS) | UC San Francisco; School of Pharmacy
Volunteer Clinical Professor | UC Davis; School of Medicine
I've been an oncology pharmacist for over 25 years and a HOPA member since 2005. I have benefitted from the professional development, committee activities and networking offered by HOPA. I have long admired HOPA's commitment to supporting the advancement of pharmacy practitioners and their vision to ensure that every person with cancer has an oncology pharmacist on their team, advocating for them and optimizing their care. I think pharmacy has struggled, as a profession, to get the public to understand the importance of their role in patient care. However, HOPA is on a path to improve that through the initiatives outlined in their strategic plan and I would like to participate in those efforts.
If selected as a member of the HOPA Board of Directors, I would work with HOPA to achieve their strategic goals and develop a platform for pharmacists to be recognized more readily as pivotal members of the healthcare team. I think this can be achieved through collaboration with other oncology and pharmacy organizations on important safety, quality and access-to-care initiatives, as well as through engaging patients, who have been impacted by oncology pharmacists, to share their experiences in a public venue. Having benefitted both personally and professionally as a HOPA member for so many years, it would be a privilege to serve HOPA as an At-Large Member of the Board of Directors.
Ashley E. Glode, PharmD, BCOP
Clinical Pharmacy Specialist – Phase I/GI/Head and Neck/Sarcoma/Multidisciplinary Oncology Clinics | University of Colorado Cancer Center
Being involved with HOPA has, without a doubt, changed my life and my oncology pharmacy career. It has provided me with a safe environment to learn and grow as a practitioner and establish connections with leaders and role models in oncology pharmacy. I have had the opportunity to hold numerous leadership positions within HOPA on committees and task forces. I could only hope to give back to the organization all it has given me.
As At-Large Director, I will be an active board member and support the membership by listening to them to work toward achieving the goals laid out in our strategic plan. In my 12 years of membership, I have seen HOPA grow and evolve in tremendous ways and I plan to be a part of its continued growth and foster the achievement of HOPA’s vision and mission. I do believe that all individuals with cancer deserve to have an oncology pharmacist on their team, and for those who work in this field, we have a responsibility to be knowledgeable on the evolving treatment landscape in order to provide optimal pharmaceutical care. I have lost relatives to the fight, and some have survived, but along the way, they all deserved to have a competent oncology pharmacist on their team and I will dedicate myself to helping HOPA achieve this goal.